LDN-193189

For research use only. Not for use in humans.

目录号：S2618 别名： DM3189

CAS No. 1062368-24-4

LDN-193189 (DM3189)是一种选择性的BMP信号通路抑制剂，抑制BMP I型受体ALK2和ALK3的转录活性，在C2C12细胞中IC50分别为5 nM和30 nM，作用于BMP比作用于TGF-β选择性高200倍。

规格

价格

库存

购买数量

2mg	RMB 898.78	现货
5mg	RMB 1402.75	现货
25mg	RMB 4664.07	现货
大包装	有超大折扣

大剂量询单有大折扣!

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的LDN-193189发表文献132篇：

Nature, 2019, 573(7774):421-425

PubMed: 31511693 ( click the link to review the publication )

Cell, 2019, 177(4):910-924

PubMed: 30982595 ( click the link to review the publication )

Nat Mater, 2018, 17(7):633-641

PubMed: 29784997 ( click the link to review the publication )

Nat Methods, 2014, 11(8):855-60

PubMed: 24930130 ( click the link to review the publication )

Cancer Cell, 2014, 26(4):521-33

PubMed: 25314078 ( click the link to review the publication )

Gastroenterology, 2014, 147(1):196-208

PubMed: 24704720 ( click the link to review the publication )

Acta Neuropathol, 2021, 141(2):257-279

PubMed: 33398403 ( click the link to review the publication )

EMBO Mol Med, 2021, e12632

PubMed: 33428810 ( click the link to review the publication )

Mol Ther, 2021, S1525-0016(20)30688-2

PubMed: 33388417 ( click the link to review the publication )

J Cell Physiol, 2021, 10.1002/jcp.30254

PubMed: 33393086 ( click the link to review the publication )

Stem Cell Res, 2021, 52:102240

PubMed: 33610017 ( click the link to review the publication )

Nature, 2021, 10.1038/s41586-021-03273-0

PubMed: 33508854 ( click the link to review the publication )

J Clin Invest, 2021, 146287

PubMed: 33630762 ( click the link to review the publication )

J Clin Invest, 2020, 130(2):942-957

PubMed: 31689244 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2020, 117(40):25092-25103

PubMed: 32958647 ( click the link to review the publication )

Genes Dev, 2020, 10.1101/gad.332494.119

PubMed: 32115408 ( click the link to review the publication )

Cell Rep, 2020, 30(3):771-782

PubMed: 31968252 ( click the link to review the publication )

Glia, 2020, 68(3):589-599

PubMed: 31670864 ( click the link to review the publication )

J Clin Endocrinol Metab, 2020, 105(1)

PubMed: 31588501 ( click the link to review the publication )

Cells, 2020, 9(10)E2288

PubMed: 33066405 ( click the link to review the publication )

FASEB J, 2020, 10.1096/fj.202001448R

PubMed: 33118211 ( click the link to review the publication )

Cell Commun Signal, 2020, 18(1):93

PubMed: 32546183 ( click the link to review the publication )

Stem Cell Res Ther, 2020, 14;11(1):62

PubMed: 32059748 ( click the link to review the publication )

Stem Cell Res Ther, 2020, 11(1):431

PubMed: 33008480 ( click the link to review the publication )
Biomolecules, 2020, 29;10(4) pii: E519

PubMed: 32235336 ( click the link to review the publication )

Sci Rep, 2020, 10(1):14474

PubMed: 32879386 ( click the link to review the publication )

J Steroid Biochem Mol Biol, 2020, 199:105587

PubMed: 32004706 ( click the link to review the publication )

J Biol Chem, 2020, 295(50):17114-17127

PubMed: 33453962 ( click the link to review the publication )

J Biol Chem, 2020, jbc.RA120.015165

PubMed: 33028637 ( click the link to review the publication )

Skelet Muscle, 2020, 2;10(1):13

PubMed: 32359374 ( click the link to review the publication )

Biol Reprod, 2020, 15;102(4):795-805

PubMed: 31965149 ( click the link to review the publication )

Biochem Biophys Res Commun, 2020, 524(2):360-365

PubMed: 32001001 ( click the link to review the publication )

Biomed Res Int, 2020, 2020:7626215

PubMed: 32596370 ( click the link to review the publication )

Mil Med Res, 2020, 7(1):42

PubMed: 32892745 ( click the link to review the publication )

Neurosci Lett, 2020, 18;716:134681

PubMed: 31836568 ( click the link to review the publication )

J Biol Chem, 2020, jbc.RA120.13352

PubMed: 32759168 ( click the link to review the publication )

Stem Cell Res Ther, 2020, 11(1):347

PubMed: 32771055 ( click the link to review the publication )

Curr Protoc Stem Cell Biol, 2020, 55(1):e120

PubMed: 32956559 ( click the link to review the publication )

Cell Death Dis, 2020, 11(3):172

PubMed: 32139667 ( click the link to review the publication )

Heliyon, 2020, 12;6(4):e03743

PubMed: 32322728 ( click the link to review the publication )

J Bone Miner Res, 2020, 10.1002

PubMed: 32212389 ( click the link to review the publication )

Commun Biol, 2020, 3(1):604

PubMed: 33097805 ( click the link to review the publication )

Metabolites, 2020, 10(8):E302

PubMed: 32717953 ( click the link to review the publication )

Nat Commun, 2019, 10(1):928

PubMed: 30804331 ( click the link to review the publication )

Nat Commun, 2019, 10(1):2612

PubMed: 31197141 ( click the link to review the publication )

Nat Commun, 2019, 10(1):3933

PubMed: 31477693 ( click the link to review the publication )

Nat Commun, 2019, 10(1):4269

PubMed: 31537794 ( click the link to review the publication )

Autophagy, 2019, 15(4):631-651

PubMed: 30335591 ( click the link to review the publication )
Autophagy, 2019, 15(6):1051-1068

PubMed: 30669930 ( click the link to review the publication )

Biomaterials, 2019, 10.1016/j.biomaterials.2019.119602

PubMed: 31735448 ( click the link to review the publication )

Thyroid, 2019, 29(11):1683-1703

PubMed: 31507237 ( click the link to review the publication )

Stem Cell Res, 2019, 41:101615

PubMed: 31704539 ( click the link to review the publication )

Stem Cell Res, 2019, 34:101368

PubMed: 30634129 ( click the link to review the publication )

Stem Cell Res, 2019, 34:101349

PubMed: 30660866 ( click the link to review the publication )

Stem Cell Reports, 2019, 13(2):338-351

PubMed: 31353224 ( click the link to review the publication )

Stem Cell Res, 2019, 40:101563

PubMed: 31494448 ( click the link to review the publication )

J Neurosci, 2019, 39(12):2184-2194

PubMed: 30696729 ( click the link to review the publication )

Glia, 2019, 67(1):146-159

PubMed: 30453390 ( click the link to review the publication )

J Clin Endocrinol Metab, 2019, 104(5):1667-1676

PubMed: 30541132 ( click the link to review the publication )

J Mol Cell Biol, 2019, 11(1):26-38

PubMed: 29771334 ( click the link to review the publication )

Mol Ther Methods Clin Dev, 2019, 13:414-430

PubMed: 31061832 ( click the link to review the publication )

J Cell Physiol, 2019, 10.1002/jcp.28247

PubMed: 30714152 ( click the link to review the publication )

Sci Rep, 2019, 9(1):1897

PubMed: 30760778 ( click the link to review the publication )

Stem Cells Int, 2019, 2019:5026793

PubMed: 31885612 ( click the link to review the publication )

Front Neurosci, 2019, 13:867

PubMed: 31551670 ( click the link to review the publication )

Am J Transl Res, 2019, 11(6):3490-3504

PubMed: 31312361 ( click the link to review the publication )

Theriogenology, 2019, 135:204-212

PubMed: 30522699 ( click the link to review the publication )

Methods Mol Biol, 2019, 2005:101-124

PubMed: 31175649 ( click the link to review the publication )

Nat Metab, 2019, 1(2):222-235

PubMed: 32694784 ( click the link to review the publication )

Nat Neurosci, 2019, 22(3):386-400

PubMed: 30742117 ( click the link to review the publication )

Nat Cell Biol, 2018, 20(8):909-916

PubMed: 30038251 ( click the link to review the publication )

ACS Appl Mater Interfaces, 2018, 10(35):29238-29250

PubMed: 30091584 ( click the link to review the publication )
Cell Rep, 2018, 25(4):1081-1096.e6

PubMed: 30355486 ( click the link to review the publication )

Nanoscale, 2018, 10(7):3556-3565

PubMed: 29410983 ( click the link to review the publication )

Stem Cell Reports, 2018, 11(3):635-650

PubMed: 30174316 ( click the link to review the publication )

Cell Death Dis, 2018, 9(9):924

PubMed: 30206204 ( click the link to review the publication )

Front Immunol, 2018, 9:647

PubMed: 29651293 ( click the link to review the publication )

Biochim Biophys Acta Mol Cell Res, 2018, 1865(9):1239-1249

PubMed: 29902488 ( click the link to review the publication )

Cell Discov, 2018, 4:49

PubMed: 30181900 ( click the link to review the publication )

J Cell Physiol, 2018, 233(9):7268-7278

PubMed: 29600572 ( click the link to review the publication )

Front Cell Neurosci, 2018, 12:348

PubMed: 30337858 ( click the link to review the publication )

Tissue Eng Part A, 2018, 24(5-6):502-515

PubMed: 28602124 ( click the link to review the publication )

Toxicol Mech Methods, 2018, 28(4):286-292

PubMed: 29161937 ( click the link to review the publication )

Mol Ther Nucleic Acids, 2018, 12:817-828

PubMed: 30153566 ( click the link to review the publication )

Nature, 2018, 563(7733):701-704

PubMed: 30429614 ( click the link to review the publication )

Nat Commun, 2017, 8:14382

PubMed: 28176763 ( click the link to review the publication )

Stem Cell Reports, 2017, 9(6):1885-1897

PubMed: 29153989 ( click the link to review the publication )

Stem Cell Reports, 2017, 9(3):883-896

PubMed: 28803915 ( click the link to review the publication )

Alzheimers Res Ther, 2017, 9(1):90

PubMed: 29191219 ( click the link to review the publication )

Cell Chem Biol, 2017, 24(7):833-844

PubMed: 28648376 ( click the link to review the publication )

Acta Neuropathol Commun, 2017, 5(1):77

PubMed: 29078805 ( click the link to review the publication )

Oxid Med Cell Longev, 2017, 2017:7601592

PubMed: 29147463 ( click the link to review the publication )

Stem Cells Transl Med, 2017, 6(9):1803-1814

PubMed: 28650520 ( click the link to review the publication )

J Cell Physiol, 2017, 232(12):3762-3774

PubMed: 28181691 ( click the link to review the publication )

Int J Mol Sci, 2017, 18(12)E2591

PubMed: 29194391 ( click the link to review the publication )

Neurochem Int, 2017, 106:48-61

PubMed: 28237843 ( click the link to review the publication )
Oncol Rep, 2017, 37(2):713-720

PubMed: 28035402 ( click the link to review the publication )

PLoS One, 2017, 12(5):e0177188

PubMed: 28489883 ( click the link to review the publication )

Mol Biosyst, 2017, 13(10):2116-2124

PubMed: 28820530 ( click the link to review the publication )

Biol Trace Elem Res, 2017, 176(2):294-304

PubMed: 27660075 ( click the link to review the publication )

Sci Rep, 2017, 7:40191

PubMed: 28057917 ( click the link to review the publication )

Biofabrication, 2017, 9(2):025007

PubMed: 28287080 ( click the link to review the publication )

Stem Cell Reports, 2017, 8(2):264-277

PubMed: 28132887 ( click the link to review the publication )

Cell, 2017, 168(3):473-486

PubMed: 28129541 ( click the link to review the publication )

Oncotarget, 2017, 8(35):58625-58641

PubMed: 28938584 ( click the link to review the publication )

Reproduction, 2017, 154(6):745-753

PubMed: 28874516 ( click the link to review the publication )

Nat Commun, 2016, 7:13516

PubMed: 27869117 ( click the link to review the publication )

Mol Cancer, 2016, 15:27

PubMed: 27048361 ( click the link to review the publication )

Stem Cell Res, 2016, 17(3):576-579

PubMed: 27934586 ( click the link to review the publication )

Stem Cell Res, 2016, 17(3):600-602

PubMed: 27934590 ( click the link to review the publication )

Stem Cell Res, 2016, 17(3):556-559

PubMed: 27789409 ( click the link to review the publication )

Stem Cell Res, 2016, 17(3):550-552

PubMed: 27789407 ( click the link to review the publication )

Stem Cell Res, 2016, 17(3):564-567

PubMed: 27789411 ( click the link to review the publication )

Oncoimmunology, 2016,

PubMed: 27999749 ( click the link to review the publication )

J Dent Res, 2016, 95(3):292-301

PubMed: 26534931 ( click the link to review the publication )

Oncol Rep, 2016, 35(2):939-47

PubMed: 26555012 ( click the link to review the publication )

Differentiation, 2016, 10.1016/j.diff.2016.06.002

PubMed: 27321088 ( click the link to review the publication )

Birth Defects Res A Clin Mol Teratol, 2016, 106(7):612-23

PubMed: 27150428 ( click the link to review the publication )

Curr Protoc Hum Genet, 2016, 90:21.5.1-21.5.14

PubMed: 27367166 ( click the link to review the publication )

J Clin Invest, 2015, 125(2):796-808

PubMed: ( click the link to review the publication )
Proc Natl Acad Sci U S A, 2015, 112(32):9990-5

PubMed: 26216950 ( click the link to review the publication )

Stem Cells, 2015, 33(5):1447-55

PubMed: 25639853 ( click the link to review the publication )

Cell Physiol Biochem, 2015, 35:1831-1845

PubMed: ( click the link to review the publication )

Connect Tissue Res, 2015, 10.3109/03008207.2015.1023433

PubMed: 25748814 ( click the link to review the publication )

Int J Cancer, 2014, 136(5):E455-69

PubMed: 25227893 ( click the link to review the publication )

J Endocrinol, 2014, 223(1):35-45

PubMed: 25100748 ( click the link to review the publication )

PLoS One, 2014, 9(12):e113785

PubMed: 25470749 ( click the link to review the publication )

Cell Mole Bioeng, 2014, 10.1007/s12195-014-0333-z

PubMed: ( click the link to review the publication )

Cell Mol Bioeng, 2014, 7(2):172-183

PubMed: 25419247 ( click the link to review the publication )

Biol Trace Elem Res, 2014, 162(1-3):18-25

PubMed: 25312381 ( click the link to review the publication )

J Cell Sci, 2013, 126(Pt 1):234-43

PubMed: 23203803 ( click the link to review the publication )

Dev Biol, 2013, 378(2):107-21

PubMed: 23583585 ( click the link to review the publication )

产品安全说明书

TGF-beta/Smad抑制剂选择性比较

生物活性

产品描述

靶点

ALK2 ^[1] (C2C12 cells)	ALK3 ^[1] (C2C12 cells)
5 nM	30 nM

体外研究

LDN193189有效抑制BMP4介导的Smad1，Smad5和Smad8活化, IC 50为5 nM，并有效地抑制BMP的I型受体ALK2和ALK3的转录活性，IC 50分别为5 nM和30 nM。此外，LDN193189还抑制组成型活性ALK2^R206H or ALK2^Q207D突变蛋白诱导的转录活性。^[1] 最近的一项研究表明在动脉粥样硬化形成的人主动脉内皮细胞中，LDN-193189阻止氧化低密度脂蛋诱导的活性氧生成。^[4]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
C2C12	NG\GZ4JMcW6jc3WgRZN{[Xl?				MonlbY5pcWKrdIOgeIhmKGurbnHz[UBi[3Srdnn0fUBw\iCDTFu0JIFv\CCDY4TSTWlCKHerdHigTWM2OMLidnHseYV{KG:oIEGwNUBidmRiMkGwJI5uNCC{ZYPw[YN1cX[nbIm=	MnGwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV\|NkizNlIoRjJ3M{[4N\|IzRC:jPh?=
EOC216	NWKxXoplT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYS0V4tnOC5zLUGwJO69VQ>?	NVXzcJRYOi1zMDDk	Ml[2SG1UVw>?	NEK5W2FqdmS3Y3WgZ4VtdCCmZXH0bEBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=>	MmDvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{Mke4PVMoRjJ3MkK3PFk{RC:jPh?=
OVAC429	NHTtUWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NH2wOIczNzVizszN	NWPFcnE4PDhiaB?=	NUPZRlE{TE2VTx?=	MUnk[YNz\WG\|ZYOgeIhmKHCncnPlcpRi\2Vib3[gZ4VtdHNiaX6gV{BxcGG\|	M1vMZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MkK3PFk{Lz5{NUKyO\|g6OzxxYU6=
SKOV3	NF2x[WdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MWKyM\|Uh\|ryP	NGLMNYQ1QCCq	MmjsSG1UVw>?	M1nlZ4Rm[3KnYYPld{B1cGVicHXyZ4VvfGGpZTDv[kBk\WyuczDpckBUKHCqYYO=	NWfNcHRLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWyNlc5QTNpPkK1NlI4QDl\|PD;hQi=>
OVCA429	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVXUZVdQOi93IN88US=>	MUO0PEBp	MX\EUXNQ	NIfsXY5l\WO{ZXHz[ZMhfGinIIDldoNmdnSjZ3Wgc4Yh[2WubIOgbY4hWyCyaHHz	MnPJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{Mke4PVMoRjJ3MkK3PFk{RC:jPh?=
EOC219	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{iyZVIwPSEQvF2=	NWO3e49yPDhiaB?=	NGDXVYJFVVOR	NVLJbnFz\GWlcnXhd4V{KHSqZTDw[ZJk\W62YXflJI9nKGOnbHzzJIlvKFNicHjhdy=>	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTJ{N{i5N{c,OjV{Mke4PVM9N2F-
A549	NGXCSmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mo\0NE42NTF4IN88US=>		NXzCeGI2TE2VTx?=	MV\pcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=>	NEW0bXU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe3PFAyOSd-MkS3O\|gxOTF:L3G+
BEAS-2B	M4K3UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Ml\lNE42NTF4IN88US=>		Mnr1SG1UVw>?	MUnpcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=>	NU\mUFc1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3O\|gxOTFpPkK0O\|c5ODFzPD;hQi=>
hBMSCs	MXPGeY5kfGmxbjDBd5NigQ>?	MX2wMlLDqM7:TR?=	M3vUfVch\A>?		M{LqOYFjd2yrc3jld{B1cGVic3nsbYJqdmmwLYDyc41wfGWmIFHMVEBi[3Srdnn0feKheGG{dHz5	M17VT\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MEe2NVg4Lz5{NEC3OlE5PzxxYU6=
PANC-1	M1TBZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Ml7lOU02ODBibl2=	MnzOOFghcA>?		NHTIWZZqdmirYnn0d{Bk\WyuIHfyc5d1cCCrbjDhJIRwe2VvZHXw[Y5l\W62IH3hco5meg>?	MlHMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7Nkm3NlkoRjJ\|OU[5O\|I6RC:jPh?=
MIA PaCa-2	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NG\NeIM2NTVyMDDuUS=>	Mm\oOFghcA>?		MW\pcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=>	M4DUUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|OU[5O\|I6Lz5{M{m2PVczQTxxYU6=
Bx-PC3	NWD3cJR[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NG\RT2o2NTVyMDDuUS=>	MXm0PEBp		NGS3W\|VqdmirYnn0d{Bk\WyuIHfyc5d1cCCrbjDhJIRwe2VvZHXw[Y5l\W62IH3hco5meg>?	NH3KOlI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m2PVczQSd-MkO5Olk4Ojl:L3G+
PC3	NEPVfVRHfW6ldHnvckBCe3OjeR?=	MorMOVAxKG6P	NUDnPYpxOiCq		NIC5O\|Vz\XC{ZYPz[ZMh[WO2aY\heIlwdiCxZjDTcYFlOS93L{igZY5lKFBvU33h[FMhdGW4ZXzz	NWC0VJV[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0OVI5QDNpPkKyOFUzQDh\|PD;hQi=>
LNCaP	MXzGeY5kfGmxbjDBd5NigQ>?	NHr1UJcx6oDVNUCwJI5O	M{W0[VIhcA>?		M{n1RZJmfmW{c3XzJJJieGGveXPpck1qdmS3Y3XkJINmdGxiZHXheIg>	NV3HWWdLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0OVI5QDNpPkKyOFUzQDh\|PD;hQi=>
EOC	NUHOR5E2TnWwY4Tpc44hSXO\|YYm=	MYSxNE0yODByIH7N	NVXMWm55PzJiaB?=		MoCwdoVlfWOnczD0bIUheGixc4Doc5J6dGG2ZXSgRm1RKFJvU33h[FEwPS96wrC=	NHLvXII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK0PVQyPSd-MkKyOFk1OTV:L3G+
HaCaT	NIjSSI9HfW6ldHnvckBCe3OjeR?=	MlzENE4xODFvMUCg{txO	MnLGNkBp		NHj5[ldqdmirYnn0d{BDVVB{LXnu[JVk\WRicHjvd5Bpd3K7bHH0bY9vKG:oIGPtZYQyNzVxODD3bZRpKGGwIFnDOVDDqG:oII6wMlAxPcLizszN	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTd2MEm2Okc,OjF5NEC5OlY9N2F-
HaCaT	MWjGeY5kfGmxbjDBd5NigQ>?	M{TpfVAvODBzLUGwJO69VQ>?	MmC4NkBp		M16x[IlvcGmkaYTzJJRp\SCjYnnsbZR6KG:oIFHMT\|IhfG9icHjvd5Bpd3K7bHH0[UBIW1RvU33h[FHDqHerdHigZY4hUUN3MNMgc4YhPDYEoH7N	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTd2MEm2Okc,OjF5NEC5OlY9N2F-
HaCaT	MofNSpVv[3Srb36gRZN{[Xl?	Ml\QNE4xODFvMUCg{txO	NWizfpk{OiCq		MWnpcohq[mm2czD0bIUh[WKrbHn0fUBw\iCDTFuzJJRwKHCqb4PwbI9zgWyjdHWgV41i\DIEoIfpeIgh[W5iSVO1NOKhd2ZiMUCwJI5O	MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTd2MEm2Okc,OjF5NEC5OlY9N2F-
HaCaT	NFTP[WpHfW6ldHnvckBCe3OjeR?=	NH\ieVYxNjByMT2xNEDPxE1?	MV:yJIg>		MoHobY5pcWKrdIOgRWxMPCCjbnSgRWxMPSC5aYToJGlEPTEEoI\hcJVmeyCxZjCwMlPDqM7:TTDhcoQhOC53wrFOwG0hemW\|cHXjeIl3\Wy7	NF7vVYg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUe0NFk3Pid-MkG3OFA6PjZ:L3G+
C2C12	MYTGeY5kfGmxbjDhd5NigQ>?		NVX4d4ZHOzBibXnudy=>		MmXDTY5pcWKrdHnvckBw\iCETWC2MYlv\HWlZXSgRWxMOiC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkhcW5ibX;1d4UhSzKFMUKgZ4VtdHNiZYjwdoV{e2mwZzDCVmUuVHWlIHHmeIVzKDNyIH3pcpMh[nlibIXjbYZmemG\|ZTDy[ZBwenSncjDn[Y5mKGG\|c3H5MEBGSzVyIE2gNE4xOTRizszNMi=>	M3f1W\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMkK3PVQ3Lz5\|MEKyO\|k1PjxxYU6=
BT-12	MYXxTHRUKGG\|c3H5				MYjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvMUKgZ4VtdHN?	NUX3fFJyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
fibroblast cell	NYrZOYg6eUiWUzDhd5NigQ>?				MUTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5Ih[2:wdILvcEBJcCC5aXzkJJR6eGViZnnido9jdGG\|dDDj[Yxtew>?	NYjYcpdSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh30	NWf3eFVIeUiWUzDhd5NigQ>?				NH;ubndyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiUnizNEBk\Wyucx?=	MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
KB-3-1	M33RUGZ2dmO2aX;uJIF{e2G7				M4LGeXAu\2y7Y3;wdo91\WmwIIP1ZpN1emG2ZYOgbYRmdnSrZnnl[EBqdiCNQj2zMVEh[WSnbn;jZZJkcW6xbXGgZ4VtdCCuaX7lMEByUFSVIITo[ZJieGW3dHnjJIxq[nKjcomgd4Nz\WWw	MmH0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzF3MUWyPFQoRjNzNUG1Nlg1RC:jPh?=
C2C12	NEK4SoJHfW6ldHnvckBie3OjeR?=	NVe1RZRKOC5zIIXN			MWHJcohq[mm2aX;uJI9nKEGOS{WgbY4hdW:3c3WgR\|JEOTJiY3XscJMh[XO\|ZYPz[YQh[XNiZHXjdoVie2ViaX6gWGdH[mW2YUGtbY5lfWOnZDDTcYFlOS93IIDoc5NxcG:{eXzheIlwdiCjdDCwMlEhfU1iYomgW4V{fGW{bjDicI91KG2ndHjv[C=>	MkW3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjhzMEOwNlUoRjJ6MUCzNFI2RC:jPh?=

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	pSMAD1 / pSMAD5 / pSMAD8 / SMAD1 / SMAD5 / SMAD8 / ID1 / SMAD4 / PARP / Cleaved PARP; PubMed: 31098401 Commun Biol In vitro molecular pharmacology of LDN-193189 and LDN-214117. Western blot analysis of time- and concentration-dependent effects on downstream signalling in response to a LDN-193189 and b LDN-214117 in DIPG cells. Increasing concentrations (0–10 µM) at 4 and 8 h are shown for SU-DIPG-VI, HSJD-DIPG-IV and HSJD-DIPG-007. GAPDH is the loading control.	31098401
Immunofluorescence	Tbx18 / Hcn4; PubMed: 30906456 Exp Ther Med Representative immunofluorescence microscopy images of epicardial progenitor cells from the four groups with staining for Hcn4 (red). The nuclei were counterstained with DAPI (blue) and the YFP expressed by the cells is apparent (scale bar, 50 µm). (Tbx18 was conjugated to YFP).	30906456
Growth inhibition assay	Cell viability; PubMed: 31098401 Commun Biol Screening of ALK2 inhibitors in vitro. Concentration-response curves for eight ALK2 inhibitors tested against three ACVR1 mutant cell cultures (HSJD-DIPG-007 (R206H), SU-DIPG-IV (G328V), HSJD-DIPG-018 (R258G), purple) and two wild-type cultures (SU-DIPG-VI, QCTB-R059, grey). a Pyrazolo[1,5-a]pyrimidines—dorsomorphin, LDN-193189, DMH1, LDN-212854. b Pyridines—K02288, LDN-214117, LDN-213844, LDN-213819. Concentration of compound is plotted on a log scale (x-axis) against cell viability (y-axis). Mean plus standard deviation are plotted from at least n = 3 experiments.	31098401

体内研究

在利用Ad.Cre条件性caALK2转基因小鼠中，与对7日龄（P7），LDN-193189（3 mg/kg,腹腔注射）导致邻近的左胫骨和腓骨在P13出现轻度钙化，并防止在P15出现放射线病变而不会造成体重减轻或生长迟缓，自发性骨折，骨质密度下降或行为异常。^[1] LDN193189通过抑制骨形态发生蛋白（BMP）6诱导的信号转导途径而斑马鱼胚胎背部化，而对血管发育无影响。^[2] 在含PCa-118b瘤小鼠中，LDN-193189削弱肿瘤生长并降低了肿瘤中的骨形成。^[3] 在低密度脂蛋白受体缺陷（LDLR-/-）小鼠中，LDN-193189有效地抑制动脉粥样硬化的发展。此外，LDN-193189也表现出对相关的血管炎，成骨活性和钙化的抑制作用。^[4]

动物实验：^[1]	- 合并 Animal Models: Ad.Cre在第7天注射到条件caALK2–转基因鼠和正常鼠中。 Dosages: 小于等于3 mg/kg Administration: 腹腔注射 (Only for Reference)

参考文献

[4] Derwall M, et al. Arterioscler Thromb Vasc Biol, 2012, 32(3), 613-622.

- 合并

溶解度 (25°C)

体外	DMSO	Insoluble
	Water	Insoluble
	Ethanol	Insoluble

* 溶解度检测是由Selleck技术部门检测的，可能会和文献中提供的溶解度有所差异，这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据 Download LDN-193189 SDF

分子量	406.48
化学式	C₂₅H₂₂N₆
CAS号	1062368-24-4
储存条件	3年-20°C 粉状 2年-80°C 溶于溶剂
别名	DM3189

动物体内配方计算器 (澄清溶液)

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

给药剂量

mg/kg

动物平均体重

每只动物给药体积

动物数量

只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）

% DMSO+ % + % Tween 80+ % ddH₂O

计算重置

计算结果:

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；

体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL ddH₂O，混匀澄清。

注意：1. 首先保证母液是澄清的；
2. 一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

质量

浓度

体积

分子量
=

×

×

*在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。

稀释计算器

用本工具协助配置特定浓度的溶液，使用的计算公式为：

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入输出 )

C1

V1

C2

V2
×

=

×

在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。.

连续稀释计算器方程

连续稀释
初始浓度:
稀释倍数:

计算结果

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

分子量计算器

通过输入化合物的化学式来计算其分子量：

注：化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量	浓度	体积	分子量
=	×	×
计算

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

TGF-beta/Smad Signaling Pathway Map

TGF-beta/Smad Inhibitors with Unique Features

选择性强的TGF-β Receptor抑制剂

GW788388 : TGF-β receptor type I/II dual inhibitor, K_i=38 nM/300 nM.
活性最高的TGF-β Receptor抑制剂

SB525334 : TGFβ receptor I (ALK5), IC50=14.3 nM.
用于临床的TGF-β Receptor抑制剂

LY2157299 : Phase II for Glioblastoma and Hepatocellular Carcinoma.
最新的TGF-β Receptor抑制剂

K02288 ^New : Potent, and selective type I BMP receptor inhibitor with IC50 of 1.1, 1.8, 6.4 nM for ALK2, ALK1 and ALK6, showing weaker inhibition on other ALKs (3, 4, 5) and ActRIIA.

研究领域

产品类型

定制您的化合物库

LDN-193189

客户使用Selleck生产的LDN-193189发表文献132篇：

产品安全说明书

TGF-beta/Smad抑制剂选择性比较

生物活性

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

参考文献

溶解度 (25°C)

化学数据 Download LDN-193189 SDF

动物体内配方计算器 (澄清溶液)

计算器

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

稀释计算器

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

连续稀释计算器方程

连续稀释

计算结果

分子量计算器

总分子量：g/mol

摩尔浓度计算器

技术支持

TGF-beta/Smad Signaling Pathway Map

TGF-beta/Smad Inhibitors with Unique Features

相关TGF-beta/Smad产品